Michael G. Kauffman
2012
In 2012, Michael G. Kauffman earned a total compensation of $463.3K as Chief Executive Officer at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $97,900 |
|---|---|
| Salary | $352,240 |
| Other | $13,138 |
| Total | $463,278 |
Kauffman received $352.2K in salary, accounting for 76% of the total pay in 2012.
Kauffman also received $97.9K in non-equity incentive plan and $13.1K in other compensation.
Rankings
In 2012, Michael G. Kauffman's compensation ranked 8,989th out of 11,487 executives tracked by ExecPay. In other words, Kauffman earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,989 out of 11,487 | 22nd |
Division Manufacturing | 3,289 out of 4,253 | 23rd |
Major group Chemicals And Allied Products | 886 out of 1,198 | 26th |
Industry group Drugs | 654 out of 920 | 29th |
Industry Pharmaceutical Preparations | 506 out of 700 | 28th |
Source: SEC filing on April 28, 2014.
Kauffman's colleagues
We found one more compensation record of an executive who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2012.
2012
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019